These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1979551)

  • 21. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
    He YG; Ross J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2723-8. PubMed ID: 1680112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts.
    Demetris AJ; Lasky S; Van Thiel DH; Starzl TE; Whiteside T
    Transplantation; 1985 Nov; 40(5):504-9. PubMed ID: 3904089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in peripheral blood double-negative T-lymphocyte (CD3+ CD4- CD8-) populations associated with acute cellular rejection after liver transplantation.
    Crosbie OM; Costello PJ; O'Farrelly C; Hegarty JE
    Liver Transpl Surg; 1998 Mar; 4(2):141-5. PubMed ID: 9516566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft.
    Dollinger MM; Howie SE; Plevris JN; Graham AM; Hayes PC; Harrison DJ
    FASEB J; 1998 Aug; 12(11):939-47. PubMed ID: 9707166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased bile duct complications in liver transplantation across the ABO barrier.
    Sanchez-Urdazpal L; Batts KP; Gores GJ; Moore SB; Sterioff S; Wiesner RH; Krom RA
    Ann Surg; 1993 Aug; 218(2):152-8. PubMed ID: 8342994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia.
    Dillon PW; Belchis D; Minnick K; Tracy T
    Tohoku J Exp Med; 1997 Jan; 181(1):33-40. PubMed ID: 9149337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte apoptosis and cell replacement in human liver allografts.
    Clouston AD; Jonsson JR; Balderson GA; Fawcett J; Lynch SV; Kelso A; Powell EE
    Transplantation; 2002 Jun; 73(11):1828-34. PubMed ID: 12085009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation.
    Kubota N; Sugitani M; Takano S; Sheikh A; Takayama T; Haga H; Tanaka K; Yamabe H
    Transpl Immunol; 2006 Jun; 16(1):60-4. PubMed ID: 16701178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-lymphocyte kinetics in acute rejection after orthotopic liver transplantation.
    Cuomo O; Sbreglia C; Militerno G; Atripaldi L; Darretta G; Perrella A; Perrella O
    Transplant Proc; 2001; 33(7-8):3303. PubMed ID: 11750414
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerance and latent cellular rejection in long-term liver transplant recipients.
    Wong T; Nouri-Aria KT; Devlin J; Portmann B; Williams R
    Hepatology; 1998 Aug; 28(2):443-9. PubMed ID: 9696010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection.
    Rygiel KA; Robertson H; Willet JD; Brain JG; Burt AD; Jones DE; Kirby JA
    Liver Transpl; 2010 May; 16(5):567-76. PubMed ID: 20440766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
    Shi LB; Zhang HW; Peng CH
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):942-6. PubMed ID: 17650415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface phenotype of mononuclear cells infiltrating bile ducts during acute and chronic liver allograft rejection.
    McCaughan GW; Davies S; Waugh J; Painter D; Gallagher ND; Thompson J; Sheil AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2201-2. PubMed ID: 2652710
    [No Abstract]   [Full Text] [Related]  

  • 38. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
    Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
    Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.